Loading...
BVMFAALR3
Market cap193mUSD
Dec 23, Last price  
10.13BRL
1D
0.00%
1Q
-33.79%
Jan 2017
-30.85%
IPO
-43.91%
Name

Centro de Imagem Diagnosticos SA

Chart & Performance

D1W1MN
BVMF:AALR3 chart
P/E
P/S
1.02
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
1.84%
Revenues
1.18b
+8.72%
184,186,000275,898,000393,149,000699,664,000951,470,0001,077,876,0001,076,918,0001,072,865,000928,787,0001,136,572,0001,085,009,0001,179,584,000
Net income
-228m
L+3.94%
28,510,00027,679,000-4,165,000-12,767,00014,792,0006,652,00040,087,00041,300,000-92,430,0001,988,000-219,243,000-227,878,000
CFO
102m
-45.38%
39,074,00017,113,00047,694,00098,556,00078,974,000134,194,000161,189,000213,410,000117,864,000149,128,000187,303,000102,304,000
Dividend
Apr 28, 20200.087297 BRL/sh
Earnings
Mar 19, 2025

Profile

Centro de Imagem Diagnósticos S.A. provides diagnostic medicine services in Brazil. Its diagnostic medicine services include imaging diagnosis and chart-based diagnosis; nuclear medicine and cytology; pathological anatomy; and clinical tests. The company also engages in the provision of health consulting, advisory, courses and lectures, and the services related to health; management of chronic diseases; scientific and technologic research and development related to diagnostic medicine; preparation, issue, publication, and distribution of newspapers, books, magazines, periodicals, and other media for the dissemination of scientific knowledge; and grant and management of business franchises. Centro de Imagem Diagnósticos S.A. was founded in 1992 and is headquartered in São Paulo, Brazil.
IPO date
Oct 28, 2016
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,179,584
8.72%
1,085,009
-4.54%
1,136,572
22.37%
Cost of revenue
1,139,859
1,097,675
1,042,464
Unusual Expense (Income)
NOPBT
39,725
(12,666)
94,108
NOPBT Margin
3.37%
8.28%
Operating Taxes
19,090
(13,991)
468
Tax Rate
48.06%
0.50%
NOPAT
20,635
1,325
93,640
Net income
(227,878)
3.94%
(219,243)
-11,128.32%
1,988
-102.15%
Dividends
(1,884)
(2,003)
Dividend yield
0.07%
0.11%
Proceeds from repurchase of equity
185,080
(3,907)
(14,255)
BB yield
-15.04%
0.15%
0.81%
Debt
Debt current
407,035
424,490
366,556
Long-term debt
1,166,169
1,178,781
967,914
Deferred revenue
Other long-term liabilities
81,296
78,200
68,794
Net debt
1,346,952
1,375,643
1,199,957
Cash flow
Cash from operating activities
102,304
187,303
149,128
CAPEX
(91,520)
(113,009)
(100,493)
Cash from investing activities
(111,150)
(142,496)
(105,698)
Cash from financing activities
8,697
196,846
(145,207)
FCF
(26,670)
110,614
15,023
Balance
Cash
218,595
220,431
127,310
Long term investments
7,657
7,197
7,203
Excess cash
167,273
173,378
77,684
Stockholders' equity
946,272
987,365
1,216,931
Invested Capital
2,167,258
2,188,177
2,241,571
ROIC
0.95%
0.06%
4.28%
ROCE
1.70%
4.06%
EV
Common stock shares outstanding
118,293
117,815
117,548
Price
10.40
-51.85%
21.60
44.29%
14.97
34.86%
Market cap
1,230,247
-51.66%
2,544,804
44.62%
1,759,694
34.31%
EV
2,603,735
3,952,668
2,993,793
EBITDA
132,855
105,071
213,712
EV/EBITDA
19.60
37.62
14.01
Interest
246,997
151,483
84,320
Interest/NOPBT
621.77%
89.60%